Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DE-101 (rivoglitazone) in Dry Eye Disease
NCT01468168Phase 2Completed
- Sponsor
- Santen Pharmaceutical
- Start
- Oct 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rivoglitazone in dry eye disease (DED), sponsored by Santen Pharmaceutical. Started Oct 2011; status: completed.
02
Drugs
rivoglitazone
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT01468168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01468168.